Pure Global

Salmonella Typhi IgG/IgM Rapid Test - India CDSCO Medical Device Registration

Salmonella Typhi IgG/IgM Rapid Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2023/000111_6aae35df0a85c99b251529b85d547efc_fa39833fd7e9e70665d3f5eb2650ad00. This device is marketed under the brand name Mediline-SA. The license holder is S.A-MEDLINE PRIVATE LIMITED, and it is classified as Device Class Class C. The approving authority is CDSCO -North Zone, Ghaziabad.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class C
Salmonella Typhi IgG/IgM Rapid Test
UID: MFG/IVD/2023/000111_6aae35df0a85c99b251529b85d547efc_fa39833fd7e9e70665d3f5eb2650ad00

Brand Name

Mediline-SA

Device Class

Class C

Approving Authority

CDSCO -North Zone, Ghaziabad

Product Information

The Typhoid IgG/IgM Rapid Test is a lateral flow immunoassay for the simultaneous detection and differentiation of anti-Salmonella typhi (Mediline-SA) IgG and IgM in human serum, plasma or whole blood. It is intended to be used as a screening test and as an aid in the diagnosis of infection with S. typhi. Any reactive specimen with the Typhoid IgG/IgM Rapid Test must be confirmed with alternative testing method(Mediline-SA)

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing